Post-Operative Early Enteral Nutrition Intolerance in Elderly Patients Undergoing Laparoscopic Gastric Cancer Surgery: Current Status and Nursing Strategies

Why It Matters

EEN intolerance prolongs recovery and raises costs; the predictive model enables targeted interventions for high‑risk elderly patients, potentially enhancing outcomes and resource use.

Key Takeaways

• 56% of elderly gastric cancer patients experienced EEN intolerance post‑surgery.
• Age ≥ 75, stage III‑IV, diabetes, radical resection, blood loss ≥ 250 ml are risks.
• Predictive score assigns 2 points per risk factor, total 0‑10.
• Cut‑off ≥ 6.5 yields 75.6% sensitivity, 88.9% specificity (AUC 0.856).
• Risk‑stratified nursing can lower intolerance, shorten stays, cut costs.

Pulse Analysis

The global rise in life expectancy has expanded the cohort of elderly patients confronting gastric cancer, a disease that still relies heavily on surgical resection for cure. Laparoscopic techniques have become the standard for this demographic because they reduce trauma and accelerate recovery, yet the physiological frailty of older adults—characterized by diminished gut motility, comorbidities, and limited nutritional reserves—makes postoperative nutritional support a delicate balancing act. Early enteral nutrition (EEN) is widely endorsed for its ability to preserve intestinal integrity and curb infection risk, but intolerance manifests as abdominal distension, diarrhea, nausea, or vomiting, jeopardizing the very benefits it seeks to deliver.

In the recent Frontiers in Nutrition study, more than half of the 346 patients evaluated suffered EEN intolerance, underscoring the magnitude of the problem. By applying Spearman correlation and logistic regression, the investigators pinpointed five robust predictors: advanced age, high tumor stage, diabetes, extensive (radical) resection, and significant intra‑operative blood loss. Translating these variables into a bedside-friendly scoring system—two points per factor—produced a model with an area under the curve of 0.856, indicating strong discriminative power. A threshold of 6.5 points correctly identified roughly three‑quarters of intolerant cases while correctly excluding nearly nine‑tenths of tolerant patients, offering clinicians a practical tool for early risk stratification.

The practical implications extend beyond prediction. For patients flagged as high‑risk, nursing teams can implement proactive measures such as tighter glycemic control, staged initiation of low‑volume feeds, abdominal massage, and vigilant monitoring for gastrointestinal symptoms. Adjusting intra‑operative techniques to limit blood loss and opting for less extensive resections when oncologically feasible may also curb intolerance rates. While the model shows promise, its single‑center, retrospective nature calls for multicenter validation and prospective trials to confirm that risk‑adjusted nutrition protocols truly shorten hospital stays, reduce complications, and lower overall healthcare expenditures. Such evidence would solidify the role of predictive analytics in peri‑operative nutrition management for the aging gastric‑cancer population.